BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1451 related articles for article (PubMed ID: 11034764)

  • 41. Tricyclic drugs for depression in children and adolescents.
    Hazell P; O'Connell D; Heathcote D; Henry D
    Cochrane Database Syst Rev; 2000; (3):CD002317. PubMed ID: 10908557
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Escitalopram versus other antidepressive agents for depression.
    Cipriani A; Santilli C; Furukawa TA; Signoretti A; Nakagawa A; McGuire H; Churchill R; Barbui C
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006532. PubMed ID: 19370639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of Antidepressants among Patients Diagnosed with Depression: A Scoping Review.
    Marasine NR; Sankhi S; Lamichhane R; Marasini NR; Dangi NB
    Biomed Res Int; 2021; 2021():6699028. PubMed ID: 33791379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacological treatment for depression during opioid agonist treatment for opioid dependence.
    Pani PP; Vacca R; Trogu E; Amato L; Davoli M
    Cochrane Database Syst Rev; 2010 Sep; (9):CD008373. PubMed ID: 20824876
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Mirtazapine versus other antidepressive agents for depression].
    Knud Larsen J
    Ugeskr Laeger; 2012 Nov; 174(46):2864-6. PubMed ID: 23153468
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries.
    Mishu MP; Uphoff E; Aslam F; Philip S; Wright J; Tirbhowan N; Ajjan RA; Al Azdi Z; Stubbs B; Churchill R; Siddiqi N
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013281. PubMed ID: 33591592
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis.
    Wilson K; Mottram P
    Int J Geriatr Psychiatry; 2004 Aug; 19(8):754-62. PubMed ID: 15290699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antidepressants for patients with tinnitus.
    Baldo P; Doree C; Lazzarini R; Molin P; McFerran DJ
    Cochrane Database Syst Rev; 2006 Oct; (4):CD003853. PubMed ID: 17054188
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tricyclic drugs for depression in children and adolescents.
    Hazell P; O'Connell D; Heathcote D; Henry D
    Cochrane Database Syst Rev; 2002; (2):CD002317. PubMed ID: 12076448
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis.
    Montgomery SA; Kasper S
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():33-40. PubMed ID: 7622822
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of an adjuvant antidepressant on the efficacy of electroconvulsive therapy: A systematic review and meta-analysis.
    Pluijms EM; Kamperman AM; Hoogendijk WJ; Birkenhäger TK; van den Broek WW
    Aust N Z J Psychiatry; 2021 Apr; 55(4):366-380. PubMed ID: 32900217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
    Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
    Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis.
    Trindade E; Menon D; Topfer LA; Coloma C
    CMAJ; 1998 Nov; 159(10):1245-52. PubMed ID: 9861221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antidepressants for patients with tinnitus.
    Baldo P; Doree C; Molin P; McFerran D; Cecco S
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD003853. PubMed ID: 22972065
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low dosage tricyclic antidepressants for depression.
    Furukawa T; McGuire H; Barbui C
    Cochrane Database Syst Rev; 2003; 2003(3):CD003197. PubMed ID: 12917952
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SSRIs versus other antidepressants for depressive disorder.
    Geddes JR; Freemantle N; Mason J; Eccles MP; Boynton J
    Cochrane Database Syst Rev; 2000; (2):CD001851. PubMed ID: 10796826
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary.
    Williams JW; Mulrow CD; Chiquette E; Noël PH; Aguilar C; Cornell J
    Ann Intern Med; 2000 May; 132(9):743-56. PubMed ID: 10787370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tricyclic drugs for depression in children and adolescents.
    Hazell P; Mirzaie M
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD002317. PubMed ID: 23780719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 73.